• Mayo Clinic to host Sixth Annual Metastatic Breast Cancer Conference

abstract 3D illustration of metastatic breast cancer that has spread to other parts of the body

ROCHESTER, Minn. — Mayo Clinic will host the Sixth Annual Metastatic Breast Cancer Conference at the Omni Scottsdale Resort and Spa at Montelucia in Scottsdale, Arizona, Sept. 19–20. This program is a joint effort among Mayo Clinic, Baylor College of Medicine, and Theresa's Research Foundation.

The Metastatic Breast Cancer Conference was established as an annual medical conference in 2014 by Theresa's Research Foundation, with leadership from Matthew Ellis, M.B., B.Chir., B.Sc., Ph.D., McNair Scholar at Baylor College of Medicine, and Danny Welch, Ph.D., at the University of Kansas Medical Center.

What sets this conference apart from other breast cancer-centered conferences is its specific focus on addressing metastatic disease as a major, but yet unmet, clinical need. Also, the conference rotates its location each year in partnership with different academic institutions.

Minetta Liu, M.D., a Mayo Clinic medical oncologist, and Michael T. Barrett, Ph.D., a Mayo Clinic hematology and oncology researcher, are this year's course directors.

"This conference provides patients, advocates, researchers, clinicians, and representatives from industry and government agencies a unique forum for discussion and collaboration," says Dr. Liu, research chair of Oncology. "Only in this way will we make more significant progress in understanding and managing metastatic breast cancer."

"We are looking forward to working with Mayo Clinic and are honored to be continuing our work with Dr. Liu," says Josh Newby, founder of Theresa's Research Foundation, and community project coordinator at Baylor College of Medicine. "With this conference, we aim to bring together those working on metastatic breast cancer, including patient advocates in order to generate breakthroughs for patients."

This meeting is intended for clinicians, researchers, patient advocates and other health care professionals involved in the research, treatment or care of patients with metastatic breast cancer. This event is approved for AMA PRA Category 1 Credits.

Session topics include:

  • "Progress in Precision Medicine for Metastatic Breast Cancer"
  • "Less Common Metastatic Breast Cancer Subtypes"
  • "Accelerating Research in Metastatic Breast Cancer"
  • "Clinical Trials in Metastatic Breast Cancer"
  • "Patient Advocacy in Metastatic Breast Cancer"
  • "Immunotherapy for Metastatic Breast Cancer"
  • "Preventing Metastatic Progression"

For information on registration and abstract submissions, visit the conference website. Limited travel stipends are available for early career investigators who have an abstract accepted contact Josh Newby at josh@theresasresearch.org for more information.


About Mayo Clinic Cancer Center
As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 1-855-776-0015.

About Mayo Clinic 
Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, comprehensive care to everyone who needs healing. Learn more about Mayo ClinicVisit the Mayo Clinic News Network

Media contact:

Related articles